SNCA and Parkinson disease: Susceptibility variants in certain genes, such as the glucosylceramidase beta (GBA), microtubule associated protein tau (MAPT), SNCA, and leucine rich repeat kinase 2 (LRRK2) genes, have also been reported to increase PD risk (8, 12).